PLK1 was shown to be overexpressed in a large spectrum of cancer types, including non-small cell lung cancer (NSCLC) [12], breast [13] ovarian [14] and head and neck squamous carcinomas [15] and melanoma [16]. This evidence concerns the gene PLK1 and cancer.